{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T22:06:34Z","timestamp":1773093994715,"version":"3.50.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-024-04408-3","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T05:02:06Z","timestamp":1718859726000},"page":"2693-2705","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The expanding role of radiation oncology across the prostate cancer continuum"],"prefix":"10.1007","volume":"49","author":[{"given":"Sasha","family":"Swensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay J.","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0053-7874","authenticated-orcid":false,"given":"Ting Martin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9988-5571","authenticated-orcid":false,"given":"Emily S.","family":"Weg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,20]]},"reference":[{"issue":"1","key":"4408_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"Rebecca L Siegel","year":"2023","unstructured":"Siegel, Rebecca L., et al. \u201cCancer Statistics, 2023.\u201d CA: A Cancer Journal for Clinicians, vol. 73, no. 1, 2023, pp. 17\u201348, https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"4408_CR2","volume-title":"Gunderson & Tepper\u2019s Clinical Radiation Oncology","author":"Joel E Tepper","year":"2020","unstructured":"Tepper, Joel E., et al., editors. Gunderson & Tepper\u2019s Clinical Radiation Oncology. 5th ed., Elsevier, 2020.","edition":"5"},{"issue":"3","key":"4408_CR3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s11934-005-0008-3","volume":"6","author":"Tony Y Eng","year":"2005","unstructured":"Eng, Tony Y., et al. \u201cThe Efficacy of Conventional External Beam, Three-Dimensional Conformal, Intensity-Modulated, Particle Beam Radiation, and Brachytherapy for Localized Prostate Cancer.\u201d Current Urology Reports, vol. 6, no. 3, May 2005, pp. 194\u2013209, https:\/\/doi.org\/10.1007\/s11934-005-0008-3.","journal-title":"Current Urology Reports"},{"issue":"4","key":"4408_CR4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/0360-3016(96)00174-5","volume":"35","author":"CC Ling","year":"1996","unstructured":"Ling, C. C., et al. \u201cConformal Radiation Treatment of Prostate Cancer Using Inversely-Planned Intensity-Modulated Photon Beams Produced with Dynamic Multileaf Collimation.\u201d International Journal of Radiation Oncology, Biology, Physics, vol. 35, no. 4, July 1996, pp. 721\u201330, https:\/\/doi.org\/10.1016\/0360-3016(96)00174-5.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"4","key":"4408_CR5","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.ijrobp.2007.11.044","volume":"70","author":"Michael J Zelefsky","year":"2008","unstructured":"Zelefsky, Michael J., et al. \u201cIncidence of Late Rectal and Urinary Toxicities after Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate Cancer.\u201d International Journal of Radiation Oncology, Biology, Physics, vol. 70, no. 4, Mar. 2008, pp. 1124\u201329, https:\/\/doi.org\/10.1016\/j.ijrobp.2007.11.044.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"6","key":"4408_CR6","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.eururo.2011.08.006","volume":"60","author":"Goenka Anuj","year":"2011","unstructured":"Goenka, Anuj, et al. \u201cImproved Toxicity Profile Following High-Dose Postprostatectomy Salvage Radiation Therapy with Intensity-Modulated Radiation Therapy.\u201d European Urology, vol. 60, no. 6, Dec. 2011, pp. 1142\u201348, https:\/\/doi.org\/10.1016\/j.eururo.2011.08.006.","journal-title":"European Urology"},{"issue":"5","key":"4408_CR7","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.ijrobp.2015.04.030","volume":"92","author":"Mariados Neil","year":"2015","unstructured":"Mariados, Neil, et al. \u201cHydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric\u00a0and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate\u00a0Image Guided Intensity Modulated Radiation\u00a0Therapy.\u201d International Journal of Radiation Oncology, Biology, Physics, vol. 92, no. 5, Aug. 2015, pp. 971\u201377, https:\/\/doi.org\/10.1016\/j.ijrobp.2015.04.030.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"11","key":"4408_CR8","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.3390\/cancers15112916","volume":"15","author":"Ladbury Colton","year":"2023","unstructured":"Ladbury, Colton, et al. \u201cClinical Applications of Magnetic Resonance-Guided Radiotherapy: A Narrative Review.\u201d Cancers, vol. 15, no. 11, May 2023, p. 2916, https:\/\/doi.org\/10.3390\/cancers15112916.","journal-title":"Cancers"},{"issue":"3","key":"4408_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1001\/jamaoncol.2022.6558","volume":"9","author":"Amar U Kishan","year":"2023","unstructured":"Kishan, Amar U., et al. \u201cMagnetic Resonance Imaging-Guided vs Computed Tomography-Guided Stereotactic Body Radiotherapy for Prostate Cancer: The MIRAGE Randomized Clinical Trial.\u201d JAMA Oncology, vol. 9, no. 3, Mar. 2023, pp. 365\u201373, https:\/\/doi.org\/10.1001\/jamaoncol.2022.6558.","journal-title":"JAMA Oncology"},{"issue":"2","key":"4408_CR10","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1016\/j.ijrobp.2023.06.1635","volume":"117","author":"AJ Wisdom","year":"2023","unstructured":"Wisdom, A. J., et al. \u201cProstate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): A Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer.\u201d International Journal of Radiation Oncology Biology Physics, vol. 117, no. 2, 2023, p. e450, https:\/\/doi.org\/10.1016\/j.ijrobp.2023.06.1635.","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"issue":"2","key":"4408_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14338\/IJPT-20-00031.1","volume":"8","author":"Curtis M Bryant","year":"2021","unstructured":"Bryant, Curtis M., et al. \u201cConsensus Statement on Proton Therapy for Prostate Cancer.\u201d International Journal of Particle Therapy, vol. 8, no. 2, 2021, pp. 1\u201316, https:\/\/doi.org\/10.14338\/IJPT-20-00031.1.","journal-title":"International Journal of Particle Therapy"},{"key":"4408_CR12","unstructured":"NCCN. National Comprehensive Cancer Network: Prostate Cancer (Version 3.2024). 2024. Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf. Accessed on 13 March 2024."},{"issue":"1","key":"4408_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/JU.0000000000002759","volume":"208","author":"James A Eastham","year":"2022","unstructured":"Eastham, James A., et al. \u201cClinically Localized Prostate Cancer: AUA\/ASTRO Guideline. Part III: Principles of Radiation and Future Directions.\u201d Journal of Urology, vol. 208, no. 1, 2022, pp. 26\u201333, https:\/\/doi.org\/10.1097\/JU.0000000000002759.","journal-title":"Journal of Urology"},{"issue":"7","key":"4408_CR14","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1200\/JCO.2009.25.8475","volume":"28","author":"Anthony L Zietman","year":"2010","unstructured":"Zietman, Anthony L., et al. \u201cRandomized Trial Comparing Conventional-Dose with High-Dose Conformal Radiation Therapy in Early-Stage Adenocarcinoma of the Prostate: Long-Term Results from Proton Radiation Oncology Group\/American College of Radiology 95-09.\u201d Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, vol. 28, no. 7, Mar. 2010, pp. 1106\u201311, https:\/\/doi.org\/10.1200\/JCO.2009.25.8475.","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"4S","key":"4408_CR15","doi-asserted-by":"publisher","first-page":"LBA259","DOI":"10.1200\/JCO.2024.42.4_suppl.LBA259","volume":"42","author":"Hennequin Christophe","year":"2024","unstructured":"Hennequin, Christophe, et al. \u201cLong-Term Results of Dose Escalation (80 vs 70 Gy) Combined with Long-Term Androgen Deprivation in High-Risk Prostate Cancers: GETUG-AFU 18 Randomized Trial.\u201d Journal of Clinical Oncology, vol. 42, no. 4_suppl, Feb. 2024, pp. LBA259\u2013LBA259, https:\/\/doi.org\/10.1200\/JCO.2024.42.4_suppl.LBA259.","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"4408_CR16","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.ijrobp.2009.12.039","volume":"79","author":"Al-Mamgani Abrahim","year":"2011","unstructured":"Al-Mamgani, Abrahim, et al. \u201cDose Escalation and Quality of Life in Patients with Localized Prostate Cancer Treated with Radiotherapy: Long-Term Results of the Dutch Randomized Dose-Escalation Trial (CKTO 96-10 Trial).\u201d International Journal of Radiation Oncology, Biology, Physics, vol. 79, no. 4, Mar. 2011, pp. 1004\u201312, https:\/\/doi.org\/10.1016\/j.ijrobp.2009.12.039.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"1","key":"4408_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ijrobp.2007.06.054","volume":"70","author":"Deborah A Kuban","year":"2008","unstructured":"Kuban, Deborah A., et al. \u201cLong-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer.\u201d International Journal of Radiation Oncology, Biology, Physics, vol. 70, no. 1, Jan. 2008, pp. 67\u201374, https:\/\/doi.org\/10.1016\/j.ijrobp.2007.06.054.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"6","key":"4408_CR18","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.prro.2018.08.002","volume":"8","author":"Scott C Morgan","year":"2018","unstructured":"Morgan, Scott C., et al. \u201cHypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline.\u201d Practical Radiation Oncology, vol. 8, no. 6, 2018, pp. 354\u201360, https:\/\/doi.org\/10.1016\/j.prro.2018.08.002.","journal-title":"Practical Radiation Oncology"},{"issue":"29","key":"4408_CR19","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1200\/JCO.2018.77.9868","volume":"36","author":"Karen E Hoffman","year":"2018","unstructured":"Hoffman, Karen E., et al. \u201cRandomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer.\u201d Journal of Clinical Oncology, vol. 36, no. 29, Oct. 2018, pp. 2943\u201349, https:\/\/doi.org\/10.1200\/JCO.2018.77.9868.","journal-title":"Journal of Clinical Oncology"},{"issue":"15","key":"4408_CR20","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1200\/JCO.19.01485","volume":"38","author":"Avkshtol Vladimir","year":"2020","unstructured":"Avkshtol, Vladimir, et al. \u201cTen-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate Cancer.\u201d Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, vol. 38, no. 15, May 2020, pp. 1676\u201384, https:\/\/doi.org\/10.1200\/JCO.19.01485.","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"20","key":"4408_CR21","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1200\/JCO.2016.67.0448","volume":"34","author":"Lee W Robert","year":"2016","unstructured":"Lee, W. Robert, et al. \u201cRandomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer.\u201d Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, vol. 34, no. 20, July 2016, pp. 2325\u201332, https:\/\/doi.org\/10.1200\/JCO.2016.67.0448.","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"8","key":"4408_CR22","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","volume":"17","author":"Dearnaley David","year":"2016","unstructured":"Dearnaley, David, et al. \u201cConventional versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy for Prostate Cancer: 5-Year Outcomes of the Randomised, Non-Inferiority, Phase 3 CHHiP Trial.\u201d The Lancet Oncology, vol. 17, no. 8, 2016, pp. 1047\u201360, https:\/\/doi.org\/10.1016\/S1470-2045(16)30102-4.","journal-title":"The Lancet Oncology"},{"issue":"4","key":"4408_CR23","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.ijrobp.2018.11.020","volume":"103","author":"RuudC Wortel","year":"2019","unstructured":"Wortel, Ruud C., et al. \u201cModerate Hypofractionation in Intermediate- and High-Risk, Localized Prostate Cancer: Health-Related Quality of Life From the Randomized, Phase 3 HYPRO Trial.\u201d International Journal of Radiation Oncology Biology Physics, vol. 103, no. 4, 2019, pp. 823\u201333, https:\/\/doi.org\/10.1016\/j.ijrobp.2018.11.020.","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"issue":"5","key":"4408_CR24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.prro.2020.02.013","volume":"10","author":"Mark A Ritter","year":"2020","unstructured":"Ritter, Mark A., et al. \u201cA Prospective Multi-Institutional Phase I\/II Trial of Step-Wise Dose-per-Fraction Escalation in Low and Intermediate Risk Prostate Cancer.\u201d Practical Radiation Oncology, vol. 10, no. 5, 2020, pp. 345\u201353, https:\/\/doi.org\/10.1016\/j.prro.2020.02.013.","journal-title":"Practical Radiation Oncology"},{"issue":"8","key":"4408_CR25","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S1470-2045(16)30070-5","volume":"17","author":"Incrocci Luca","year":"2016","unstructured":"Incrocci, Luca, et al. \u201cHypofractionated versus Conventionally Fractionated Radiotherapy for Patients with Localised Prostate Cancer (HYPRO): Final Efficacy Results from a Randomised, Multicentre, Open-Label, Phase 3 Trial.\u201d The Lancet Oncology, vol. 17, no. 8, 2016, pp. 1061\u201369, https:\/\/doi.org\/10.1016\/S1470-2045(16)30070-5.","journal-title":"The Lancet Oncology"},{"issue":"10196","key":"4408_CR26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","volume":"394","author":"Widmark Anders","year":"2019","unstructured":"Widmark, Anders, et al. \u201cUltra-Hypofractionated versus Conventionally Fractionated Radiotherapy for Prostate Cancer: 5-Year Outcomes of the HYPO-RT-PC Randomised, Non-Inferiority, Phase 3 Trial.\u201d The Lancet, vol. 394, no. 10196, 2019, pp. 385\u201395, https:\/\/doi.org\/10.1016\/S0140-6736(19)31131-6.","journal-title":"The Lancet"},{"issue":"4","key":"4408_CR27","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.ijrobp.2019.03.051","volume":"104","author":"William C Jackson","year":"2019","unstructured":"Jackson, William C., et al. \u201cStereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies.\u201d International Journal of Radiation Oncology, Biology, Physics, vol. 104, no. 4, July 2019, pp. 778\u201389, https:\/\/doi.org\/10.1016\/j.ijrobp.2019.03.051.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"11","key":"4408_CR28","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S1470-2045(19)30569-8","volume":"20","author":"Douglas H Brand","year":"2019","unstructured":"Brand, Douglas H., et al. \u201cIntensity-Modulated Fractionated Radiotherapy versus Stereotactic Body Radiotherapy for Prostate Cancer (PACE-B): Acute Toxicity Findings from an International, Randomised, Open-Label, Phase 3, Non-Inferiority Trial.\u201d The Lancet Oncology, vol. 20, no. 11, 2019, pp. 1531\u201343, https:\/\/doi.org\/10.1016\/S1470-2045(19)30569-8.","journal-title":"The Lancet Oncology"},{"issue":"3","key":"4408_CR29","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.ijrobp.2021.01.016","volume":"110","author":"van Dams Ritchell","year":"2021","unstructured":"van Dams, Ritchell, et al. \u201cStereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients.\u201d International Journal of Radiation Oncology, Biology, Physics, vol. 110, no. 3, July 2021, pp. 731\u201337, https:\/\/doi.org\/10.1016\/j.ijrobp.2021.01.016.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"10","key":"4408_CR30","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/S1470-2045(22)00517-4","volume":"23","author":"Alison C Tree","year":"2022","unstructured":"Tree, Alison C., et al. \u201cIntensity-Modulated Radiotherapy versus Stereotactic Body Radiotherapy for Prostate Cancer (PACE-B): 2-Year Toxicity Results from an Open-Label, Randomised, Phase 3, Non-Inferiority Trial.\u201d The Lancet Oncology, vol. 23, no. 10, 2022, pp. 1308\u201320, https:\/\/doi.org\/10.1016\/S1470-2045(22)00517-4.","journal-title":"The Lancet Oncology"},{"issue":"4","key":"4408_CR31","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/j.ijrobp.2023.08.027","volume":"117","author":"N Van As","year":"2023","unstructured":"Van As, N., et al. \u201c5-Year Outcomes from PACE B: An International Phase III Randomized Controlled Trial Comparing Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Fractionated or Moderately Hypo Fractionated External Beam Radiotherapy for Localized Prostate Cancer.\u201d International Journal of Radiation Oncology Biology Physics, vol. 117, no. 4, 2023, pp. e2\u20133, https:\/\/doi.org\/10.1016\/j.ijrobp.2023.08.027.","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"issue":"4","key":"4408_CR32","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S1470-2045(14)70040-3","volume":"15","author":"David P Dearnaley","year":"2014","unstructured":"Dearnaley, David P., et al. \u201cEscalated-Dose versus Control-Dose Conformal Radiotherapy for Prostate Cancer: Long-Term Results from the MRC RT01 Randomised Controlled Trial.\u201d The Lancet Oncology, vol. 15, no. 4, 2014, pp. 464\u201373, https:\/\/doi.org\/10.1016\/S1470-2045(14)70040-3.","journal-title":"The Lancet Oncology"},{"issue":"6","key":"4408_CR33","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.0039","volume":"4","author":"Jeff M Michalski","year":"2018","unstructured":"Michalski, Jeff M., et al. \u201cEffect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial.\u201d JAMA Oncology, vol. 4, no. 6, June 2018, p. e180039, https:\/\/doi.org\/10.1001\/jamaoncol.2018.0039.","journal-title":"JAMA Oncology"},{"issue":"4","key":"4408_CR34","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/COC.0000000000000285","volume":"41","author":"Nicholas G Zaorsky","year":"2018","unstructured":"Zaorsky, Nicholas G., et al. \u201cImpact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities.\u201d American Journal of Clinical Oncology, vol. 41, no. 4, 2018, pp. 409\u201315, https:\/\/doi.org\/10.1097\/COC.0000000000000285.","journal-title":"American Journal of Clinical Oncology"},{"issue":"5","key":"4408_CR35","doi-asserted-by":"publisher","first-page":"e787","DOI":"10.1016\/j.ijrobp.2011.11.030","volume":"82","author":"Arrayeh Elnasif","year":"2012","unstructured":"Arrayeh, Elnasif, et al. \u201cDoes Local Recurrence of Prostate Cancer after Radiation Therapy Occur at the Site of Primary Tumor? Results of a Longitudinal MRI and MRSI Study.\u201d International Journal of Radiation Oncology, Biology, Physics, vol. 82, no. 5, Apr. 2012, pp. e787\u2013793, https:\/\/doi.org\/10.1016\/j.ijrobp.2011.11.030.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"3","key":"4408_CR36","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0360-3016(02)02795-5","volume":"53","author":"Cellini Numa","year":"2002","unstructured":"Cellini, Numa, et al. \u201cAnalysis of Intraprostatic Failures in Patients Treated with Hormonal Therapy and Radiotherapy: Implications for Conformal Therapy Planning.\u201d International Journal of Radiation Oncology Biology Physics, vol. 53, no. 3, 2002, pp. 595\u201399, https:\/\/doi.org\/10.1016\/S0360-3016(02)02795-5.","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"issue":"7","key":"4408_CR37","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1200\/JCO.20.02873","volume":"39","author":"Linda GW Kerkmeijer","year":"2021","unstructured":"Kerkmeijer, Linda G. W., et al. \u201cFocal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial.\u201d Journal of Clinical Oncology, vol. 39, no. 7, Mar. 2021, pp. 787\u201396, https:\/\/doi.org\/10.1200\/JCO.20.02873.","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"4408_CR38","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ijrobp.2022.09.058","volume":"115","author":"Alison C Tree","year":"2023","unstructured":"Tree, Alison C., et al. \u201cStandard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: 5-Year Efficacy and Toxicity in the DELINEATE Trial.\u201d International Journal of Radiation Oncology Biology Physics, vol. 115, no. 2, 2023, pp. 305\u201316, https:\/\/doi.org\/10.1016\/j.ijrobp.2022.09.058.","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"issue":"5","key":"4408_CR39","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3322\/caac.21578","volume":"69","author":"Chargari Cyrus","year":"2019","unstructured":"Chargari, Cyrus, et al. \u201cBrachytherapy: An Overview for Clinicians.\u201d CA: A Cancer Journal for Clinicians, vol. 69, no. 5, Sept. 2019, pp. 386\u2013401, https:\/\/doi.org\/10.3322\/caac.21578.","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"7","key":"4408_CR40","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrurol.2017.76","volume":"14","author":"Nicholas G Zaorsky","year":"2017","unstructured":"Zaorsky, Nicholas G., et al. \u201cThe Evolution of Brachytherapy for Prostate Cancer.\u201d Nature Reviews Urology, vol. 14, no. 7, 2017, pp. 415\u201339, https:\/\/doi.org\/10.1038\/nrurol.2017.76.","journal-title":"Nature Reviews Urology"},{"issue":"1","key":"4408_CR41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.brachy.2011.07.005","volume":"11","author":"Brian J Davis","year":"2012","unstructured":"Davis, Brian J., et al. \u201cAmerican Brachytherapy Society Consensus Guidelines for Transrectal Ultrasound-Guided Permanent Prostate Brachytherapy.\u201d Brachytherapy, vol. 11, no. 1, 2012, pp. 6\u201319, https:\/\/doi.org\/10.1016\/j.brachy.2011.07.005.","journal-title":"Brachytherapy"},{"issue":"6","key":"4408_CR42","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.brachy.2021.07.006","volume":"20","author":"Martin T King","year":"2021","unstructured":"King, Martin T., et al. \u201cLow Dose Rate Brachytherapy for Primary Treatment of Localized Prostate Cancer: A Systemic Review and Executive Summary of an Evidence-Based Consensus Statement.\u201d Brachytherapy, vol. 20, no. 6, 2021, pp. 1114\u201329, https:\/\/doi.org\/10.1016\/j.brachy.2021.07.006.","journal-title":"Brachytherapy"},{"issue":"24","key":"4408_CR43","doi-asserted-by":"publisher","first-page":"4035","DOI":"10.1200\/JCO.22.01856","volume":"41","author":"Jeff M Michalski","year":"2023","unstructured":"Michalski, Jeff M., et al. \u201cEffect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial.\u201d Journal of Clinical Oncology, vol. 41, no. 24, Aug. 2023, pp. 4035\u201344, https:\/\/doi.org\/10.1200\/JCO.22.01856.","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"4408_CR44","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ijrobp.2016.11.026","volume":"98","author":"Morris W James","year":"2017","unstructured":"Morris, W. James, et al. \u201cAndrogen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a\u00a0Low-Dose-Rate Brachytherapy Boost to a\u00a0Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer.\u201d International Journal of Radiation Oncology, Biology, Physics, vol. 98, no. 2, June 2017, pp. 275\u201385, https:\/\/doi.org\/10.1016\/j.ijrobp.2016.11.026.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"5","key":"4408_CR45","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ijrobp.2022.11.005","volume":"115","author":"Oh Justin","year":"2023","unstructured":"Oh, Justin, et al. \u201cAn Updated Analysis of the Survival Endpoints of ASCENDE-RT.\u201d International Journal of Radiation Oncology Biology Physics, vol. 115, no. 5, 2023, pp. 1061\u201370, https:\/\/doi.org\/10.1016\/j.ijrobp.2022.11.005.","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"issue":"6","key":"4408_CR46","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.brachy.2014.03.002","volume":"13","author":"Demanes D Jeffrey","year":"2014","unstructured":"Demanes, D. Jeffrey, and Michel I. Ghilezan. \u201cHigh-Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer.\u201d Brachytherapy, vol. 13, no. 6, 2014, pp. 529\u201341, https:\/\/doi.org\/10.1016\/j.brachy.2014.03.002.","journal-title":"Brachytherapy"},{"key":"4408_CR47","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.radonc.2020.09.047","volume":"154","author":"Peter J Hoskin","year":"2021","unstructured":"Hoskin, Peter J., et al. \u201cRandomised Trial of External-Beam Radiotherapy Alone or with High-Dose-Rate Brachytherapy for Prostate Cancer: Mature 12-Year Results.\u201d Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology, vol. 154, Jan. 2021, pp. 214\u201319, https:\/\/doi.org\/10.1016\/j.radonc.2020.09.047.","journal-title":"Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology"},{"issue":"1","key":"4408_CR48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2967\/jnumed.121.263262","volume":"63","author":"Jadvar Hossein","year":"2022","unstructured":"Jadvar, Hossein, et al. \u201cAppropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging.\u201d Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, vol. 63, no. 1, Jan. 2022, pp. 59\u201368, https:\/\/doi.org\/10.2967\/jnumed.121.263262.","journal-title":"Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine"},{"issue":"16","key":"4408_CR49","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1200\/JCO.2006.09.6495","volume":"25","author":"Gregory P Swanson","year":"2007","unstructured":"Swanson, Gregory P., et al. \u201cPredominant Treatment Failure in Postprostatectomy Patients Is Local: Analysis of Patterns of Treatment Failure in SWOG 8794.\u201d Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, vol. 25, no. 16, June 2007, pp. 2225\u201329, https:\/\/doi.org\/10.1200\/JCO.2006.09.6495.","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"9485","key":"4408_CR50","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(05)67101-2","volume":"366","author":"Bolla Michel","year":"2005","unstructured":"Bolla, Michel, et al. \u201cPostoperative Radiotherapy after Radical Prostatectomy: A Randomised Controlled Trial (EORTC Trial 22911).\u201d Lancet (London, England), vol. 366, no. 9485, Aug. 2005, pp. 572\u201378, https:\/\/doi.org\/10.1016\/S0140-6736(05)67101-2.","journal-title":"Lancet (London, England)"},{"issue":"2","key":"4408_CR51","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2014.03.011","volume":"66","author":"Wiegel Thomas","year":"2014","unstructured":"Wiegel, Thomas, et al. \u201cAdjuvant Radiotherapy versus Wait-and-See after Radical Prostatectomy: 10-Year Follow-up of the ARO 96-02\/AUO AP 09\/95 Trial.\u201d European Urology, vol. 66, no. 2, Aug. 2014, pp. 243\u201350, https:\/\/doi.org\/10.1016\/j.eururo.2014.03.011.","journal-title":"European Urology"},{"key":"4408_CR52","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/JU.0000000000000295","volume":"202","author":"TM Pisansky","year":"2019","unstructured":"Pisansky TM, Thompson IM, Valicenti RK et al: Adjuvant and salvage radiotherapy after prostatectomy: ASTRO\/AUA Guideline amendment 2018e2019. J Urol 2019; 202: 533.","journal-title":"J Urol"},{"issue":"1","key":"4408_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2008.04.013","volume":"88","author":"Scott C Morgan","year":"2008","unstructured":"Morgan, Scott C., et al. \u201cAdjuvant Radiotherapy Following Radical Prostatectomy for Pathologic T3 or Margin-Positive Prostate Cancer: A Systematic Review and Meta-Analysis.\u201d Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology, vol. 88, no. 1, July 2008, pp. 1\u20139, https:\/\/doi.org\/10.1016\/j.radonc.2008.04.013.","journal-title":"Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology"},{"issue":"10260","key":"4408_CR54","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/S0140-6736(20)31952-8","volume":"396","author":"Claire L Vale","year":"2020","unstructured":"Vale, Claire L., et al. \u201cAdjuvant or Early Salvage Radiotherapy for the Treatment of Localised and Locally Advanced Prostate Cancer: A Prospectively Planned Systematic Review and Meta-Analysis of Aggregate Data.\u201d Lancet (London, England), vol. 396, no. 10260, Oct. 2020, pp. 1422\u201331, https:\/\/doi.org\/10.1016\/S0140-6736(20)31952-8.","journal-title":"Lancet (London, England)"},{"issue":"10338","key":"4408_CR55","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1016\/S0140-6736(21)01790-6","volume":"399","author":"Pollack Alan","year":"2022","unstructured":"Pollack, Alan, et al. \u201cThe Addition of Androgen Deprivation Therapy and Pelvic Lymph Node Treatment to Prostate Bed Salvage Radiotherapy (NRG Oncology\/RTOG 0534 SPPORT): An International, Multicentre, Randomised Phase 3 Trial.\u201d Lancet (London, England), vol. 399, no. 10338, May 2022, pp. 1886\u2013901, https:\/\/doi.org\/10.1016\/S0140-6736(21)01790-6.","journal-title":"Lancet (London, England)"},{"issue":"6","key":"4408_CR56","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S1470-2045(16)00111-X","volume":"17","author":"Carrie Christian","year":"2016","unstructured":"Carrie, Christian, et al. \u201cSalvage Radiotherapy with or without Short-Term Hormone Therapy for Rising Prostate-Specific Antigen Concentration after Radical Prostatectomy (GETUG-AFU 16): A Randomised, Multicentre, Open-Label Phase 3 Trial.\u201d The Lancet. Oncology, vol. 17, no. 6, June 2016, pp. 747\u201356, https:\/\/doi.org\/10.1016\/S1470-2045(16)00111-X.","journal-title":"The Lancet. Oncology"},{"issue":"5","key":"4408_CR57","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1607529","volume":"376","author":"William U Shipley","year":"2017","unstructured":"Shipley, William U., et al. \u201cRadiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.\u201d The New England Journal of Medicine, vol. 376, no. 5, Feb. 2017, pp. 417\u201328, https:\/\/doi.org\/10.1056\/NEJMoa1607529.","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"4408_CR58","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.eururo.2020.11.010","volume":"80","author":"Luca F Valle","year":"2021","unstructured":"Valle, Luca F., et al. \u201cA Systematic Review and Meta-Analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER).\u201d European Urology, vol. 80, no. 3, Sept. 2021, pp. 280\u201392, https:\/\/doi.org\/10.1016\/j.eururo.2020.11.010.","journal-title":"European Urology"},{"issue":"2","key":"4408_CR59","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.euo.2018.12.011","volume":"3","author":"Ingrosso Gianluca","year":"2020","unstructured":"Ingrosso, Gianluca, et al. \u201cNonsurgical Salvage Local Therapies for Radiorecurrent Prostate Cancer: A Systematic Review and Meta-Analysis.\u201d European Urology Oncology, vol. 3, no. 2, Apr. 2020, pp. 183\u201397, https:\/\/doi.org\/10.1016\/j.euo.2018.12.011.","journal-title":"European Urology Oncology"},{"issue":"6","key":"4408_CR60","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.prro.2023.05.012","volume":"13","author":"Krishnan R Patel","year":"2023","unstructured":"Patel, Krishnan R., et al. \u201cA Phase 1 Trial of Focal Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer.\u201d Practical Radiation Oncology, vol. 13, no. 6, 2023, pp. 540\u201350, https:\/\/doi.org\/10.1016\/j.prro.2023.05.012.","journal-title":"Practical Radiation Oncology"},{"issue":"2","key":"4408_CR61","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ijrobp.2019.10.014","volume":"106","author":"Fuller Donald","year":"2020","unstructured":"Fuller, Donald, et al. \u201cRetreatment for Local Recurrence of Prostatic Carcinoma After Prior Therapeutic Irradiation: Efficacy and Toxicity of HDR-Like SBRT.\u201d International Journal of Radiation Oncology, Biology, Physics, vol. 106, no. 2, Feb. 2020, pp. 291\u201399, https:\/\/doi.org\/10.1016\/j.ijrobp.2019.10.014.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"5","key":"4408_CR62","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ijrobp.2021.10.138","volume":"112","author":"Crook Juanita","year":"2022","unstructured":"Crook, Juanita, et al. \u201cSalvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology\/RTOG 0526).\u201d International Journal of Radiation Oncology, Biology, Physics, vol. 112, no. 5, Apr. 2022, pp. 1115\u201322, https:\/\/doi.org\/10.1016\/j.ijrobp.2021.10.138.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"2","key":"4408_CR63","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.brachy.2013.11.005","volume":"13","author":"Yamada Yoshiya","year":"2014","unstructured":"Yamada, Yoshiya, et al. \u201cA Phase II Study of Salvage High-Dose-Rate Brachytherapy for the Treatment of Locally Recurrent Prostate Cancer after Definitive External Beam Radiotherapy.\u201d Brachytherapy, vol. 13, no. 2, 2014, pp. 111\u201316. https:\/\/doi.org\/10.1016\/j.brachy.2013.11.005.","journal-title":"Brachytherapy"},{"issue":"4","key":"4408_CR64","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.eururo.2021.06.010","volume":"80","author":"Supiot St\u00e9phane","year":"2021","unstructured":"Supiot, St\u00e9phane, et al. \u201cOLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-Dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer.\u201d European Urology, vol. 80, no. 4, 2021, pp. 405\u201314, https:\/\/doi.org\/10.1016\/j.eururo.2021.06.010.","journal-title":"European Urology"},{"key":"4408_CR65","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.radonc.2020.06.029","volume":"150","author":"Franzese Ciro","year":"2020","unstructured":"Franzese, Ciro, et al. \u201cAssessing the Role of Stereotactic Body Radiation Therapy in a Large Cohort of Patients with Lymph Node Oligometastases: Does It Affect Systemic Treatment\u2019s Intensification?\u201d Radiotherapy and Oncology, vol. 150, 2020, pp. 184\u201390, https:\/\/doi.org\/10.1016\/j.radonc.2020.06.029.","journal-title":"Radiotherapy and Oncology"},{"issue":"8","key":"4408_CR66","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.3390\/medicina59081442","volume":"59","author":"Cuccia Francesco","year":"2023","unstructured":"Cuccia, Francesco, et al. \u201cStereotactic Body Radiotherapy for Lymph-Nodal Oligometastatic Prostate Cancer: A Multicenter Retrospective Experience.\u201d Medicina (Kaunas, Lithuania), vol. 59, no. 8, Aug. 2023, p. 1442, https:\/\/doi.org\/10.3390\/medicina59081442.","journal-title":"Medicina (Kaunas, Lithuania)"},{"issue":"2","key":"4408_CR67","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.euf.2020.12.010","volume":"7","author":"Zilli Thomas","year":"2021","unstructured":"Zilli, Thomas, et al. \u201cThe Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases.\u201d European Urology Focus, vol. 7, no. 2, 2021, pp. 241\u201344, https:\/\/doi.org\/10.1016\/j.euf.2020.12.010.","journal-title":"European Urology Focus"},{"issue":"8","key":"4408_CR68","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1056\/NEJMoa1503747","volume":"373","author":"Christopher J Sweeney","year":"2015","unstructured":"Sweeney, Christopher J., et al. \u201cChemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.\u201d New England Journal of Medicine, vol. 373, no. 8, Aug. 2015, pp. 737\u201346, https:\/\/doi.org\/10.1056\/NEJMoa1503747.","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"4408_CR69","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/S1470-2045(19)30082-8","volume":"20","author":"Fizazi Karim","year":"2019","unstructured":"Fizazi, Karim, et al. \u201cAbiraterone Acetate plus Prednisone in Patients with Newly Diagnosed High-Risk Metastatic Castration-Sensitive Prostate Cancer (LATITUDE): Final Overall Survival Analysis of a Randomised, Double-Blind, Phase 3 Trial.\u201d The Lancet Oncology, vol. 20, no. 5, 2019, pp. 686\u2013700, https:\/\/doi.org\/10.1016\/S1470-2045(19)30082-8.","journal-title":"The Lancet Oncology"},{"key":"4408_CR70","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_390166","volume":"43","author":"Anis A Hamid","year":"2023","unstructured":"Hamid, Anis A., et al. \u201cMetastatic Hormone-Sensitive Prostate Cancer: Toward an Era of Adaptive and Personalized Treatment.\u201d American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting, vol. 43, May 2023, p. e390166, https:\/\/doi.org\/10.1200\/EDBK_390166.","journal-title":"American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting"},{"issue":"10162","key":"4408_CR71","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1016\/S0140-6736(18)32486-3","volume":"392","author":"Christopher C Parker","year":"2018","unstructured":"Parker, Christopher C., et al. \u201cRadiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE): A Randomised Controlled Phase 3 Trial.\u201d The Lancet, vol. 392, no. 10162, 2018, pp. 2353\u201366, https:\/\/doi.org\/10.1016\/S0140-6736(18)32486-3.","journal-title":"The Lancet"},{"issue":"17S","key":"4408_CR72","doi-asserted-by":"publisher","first-page":"LBA5000","DOI":"10.1200\/JCO.2023.41.17_suppl.LBA5000","volume":"41","author":"Bossi Alberto","year":"2023","unstructured":"Bossi, Alberto, et al. \u201cProstate Irradiation in Men with de Novo, Low-Volume, Metastatic, Castration-Sensitive Prostate Cancer (MCSPC): Results of PEACE-1, a Phase 3 Randomized Trial with a 2x2 Design.\u201d Journal of Clinical Oncology, vol. 41, no. 17_suppl, June 2023, pp. LBA5000\u2013LBA5000, https:\/\/doi.org\/10.1200\/JCO.2023.41.17_suppl.LBA5000.","journal-title":"Journal of Clinical Oncology"},{"key":"4408_CR73","unstructured":"SWOG Cancer Research Network. \u201cSWOG 1802: Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer.\u201d ClinicalTrials.Gov ID, 25 Mar. 2024, https:\/\/clinicaltrials.gov\/study\/NCT03678025."},{"issue":"5","key":"4408_CR74","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1200\/JCO.2017.75.4853","volume":"36","author":"Ost Piet","year":"2018","unstructured":"Ost, Piet, et al. \u201cSurveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial.\u201d Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, vol. 36, no. 5, Feb. 2018, pp. 446\u201353, https:\/\/doi.org\/10.1200\/JCO.2017.75.4853.","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"5","key":"4408_CR75","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","volume":"6","author":"Phillips Ryan","year":"2020","unstructured":"Phillips, Ryan, et al. \u201cOutcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial.\u201d JAMA Oncology, vol. 6, no. 5, May 2020, pp. 650\u201359, https:\/\/doi.org\/10.1001\/jamaoncol.2020.0147.","journal-title":"JAMA Oncology"},{"issue":"11","key":"4408_CR76","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S1470-2045(10)70223-0","volume":"11","author":"Bolla Michel","year":"2010","unstructured":"Bolla, Michel, et al. \u201cExternal Irradiation with or without Long-Term Androgen Suppression for Prostate Cancer with High Metastatic Risk: 10-Year Results of an EORTC Randomised Study.\u201d The Lancet. Oncology, vol. 11, no. 11, Nov. 2010, pp. 1066\u201373, https:\/\/doi.org\/10.1016\/S1470-2045(10)70223-0.","journal-title":"The Lancet. Oncology"},{"issue":"2","key":"4408_CR77","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S1470-2045(21)00705-1","volume":"23","author":"Amar U Kishan","year":"2022","unstructured":"Kishan, Amar U., et al. \u201cAndrogen Deprivation Therapy Use and Duration with Definitive Radiotherapy for Localised Prostate Cancer: An Individual Patient Data Meta-Analysis.\u201d The Lancet Oncology, vol. 23, no. 2, 2022, pp. 304\u201316, https:\/\/doi.org\/10.1016\/S1470-2045(21)00705-1.","journal-title":"The Lancet Oncology"},{"key":"4408_CR78","doi-asserted-by":"publisher","first-page":"109544","DOI":"10.1016\/j.radonc.2023.109544","volume":"183","author":"Schmidt-Hegemann Nina-Sophie","year":"2023","unstructured":"Schmidt-Hegemann, Nina-Sophie, et al. \u201cESTRO-ACROP Recommendations for Evidence-Based Use of Androgen Deprivation Therapy in Combination with External-Beam Radiotherapy in Prostate Cancer.\u201d Radiotherapy and Oncology, vol. 183, 2023, p. 109544, https:\/\/doi.org\/10.1016\/j.radonc.2023.109544.","journal-title":"Radiotherapy and Oncology"},{"issue":"3","key":"4408_CR79","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1210\/endrev\/bnab002","volume":"42","author":"Desai Kunal","year":"2021","unstructured":"Desai, Kunal, et al. \u201cHormonal Therapy for Prostate Cancer.\u201d Endocrine Reviews, vol. 42, no. 3, May 2021, pp. 354\u201373, https:\/\/doi.org\/10.1210\/endrev\/bnab002.","journal-title":"Endocrine Reviews"},{"key":"4408_CR80","unstructured":"NRG-GU011: A Phase II Double-Blinded, Placebo Controlled Trial of Prostate Oligometastatic Radiotherapy with or without Androgen Deprivation Therapy in Oligometastatic Prostate Cancer (NRG Promethean). https:\/\/www.nrgoncology.org\/Clinical-Trials\/Protocol\/nrg-gu011?filter=nrg-gu011. Accessed 25 Mar. 2024."}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04408-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-024-04408-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04408-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T06:05:47Z","timestamp":1722837947000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-024-04408-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,20]]},"references-count":80,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["4408"],"URL":"https:\/\/doi.org\/10.1007\/s00261-024-04408-3","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,20]]},"assertion":[{"value":"31 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}